Raising the Bar for Patient Outcomes With Immunotherapy in Early-Stage Resectable NSCLC

Access Activity

Overview / Abstract:

Target Audience
The target audience for this educational initiative is oncologists, oncology NPs, PAs, and nurses, pulmonologists, pulmonology NPs and PAs, pathologists, and pharmacists.

Program Overview
Are you up to date on the role of immunotherapy in the setting of non-small cell lung cancer (NSCLC)? In this educational activity, experts Heather Wakelee, MD, and Meghan Ramsey, MD, explore how to select patients with early-stage resectable NSCLC who may derive benefit from immunotherapy and how to recommend immunotherapy for NSCLC according to clinical data and patient-specific factors. This immersive activity will challenge your clinical decision-making specific to NSCLC through two patient case scenarios developed to demonstrate pathways to improving patient care for patients with NSCLC.

Learning Objectives
Upon completion of this educational activity, learners should be better able to:

SELECT patients with early-stage resectable NSCLC who may derive benefit from immunotherapy
RECOMMEND immunotherapy as a component of multimodal therapy in early-stage resectable NSCLC according to recent clinical trial data and patient preferences

Expiration

Dec 01, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™

Accreditation

ACCME

Presenters / Authors / Faculty

Faculty
Heather Wakelee, MD, FASCO (Chair)
Professor of Medicine
Chief, Division of Oncology
Stanford University School of Medicine
Interim Medical Director, Stanford Cancer Center
Deputy Director, Stanford Cancer Institute
President, International Association for the Study of Lung Cancer (IASLC)
Stanford, CA

Heather Wakelee, MD, FASCO, is a Professor of Medicine and Chief of the Division of Oncology at Stanford University, Deputy Director of the Stanford Cancer Institute, and Interim Medical Director of the Stanford Cancer Center. Dr Wakelee serves as the President of the International Association for the Study of Lung Cancer (IASLC). She is a Fellow of the American Society of Clinical Oncology (FASCO). Dr Wakelee is a graduate of Princeton University and Johns Hopkins University School of Medicine. She completed her postgraduate training at Stanford University.

As an experienced lung cancer investigator, Dr Wakelee has authored or co-authored over 200 medical articles on lung cancer and thymic malignancies. She is involved in dozens of clinical trials involving adjuvant therapy, immunotherapy, and anti-angiogenesis agents. Her research focuses on many specific lung cancer subtypes defined by specific mutations in EGFR, ALK, ROS1, RET, BRAF, and others. Her translational efforts have involved collaborations with colleagues in medical oncology, thoracic radiation oncology, thoracic surgery, radiology, pulmonary medicine, and population sciences

Meghan Ramsey, MD
Clinical Associate Professor
Division of Pulmonary, Allergy, and Critical Care Medicine
Critical Care Medicine Fellowship Program Director
Stanford University School of Medicine
Interim ICU Medical Director
Stanford Health Care ValleyCare
Stanford, CA

Meghan Ramsey, MD, is a Clinical Associate Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University. She received her undergraduate degree from Lafayette College in Easton, Pennsylvania, with a major in Neuroscience. Dr Ramsey received her medical degree from Stanford University, where she stayed to complete her internal medicine residency and pulmonary/critical care fellowship.

Dr Ramsey’s clinical time is split between the inpatient setting in the medical ICU and the ambulatory setting in Interventional Pulmonology with a focus on thoracic malignancies. Outside of her clinical time she has a dedicated commitment to teaching, serving as a mentor for residents and fellows, as well as leading as a co-director the pulmonary physiology course for medical students.

Sponsors / Supporters / Grant Providers

Genentech

Keywords / Search Terms

Relias LLC Relias LLC., FreeCME., Immunotherapy Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map